Table 1 Patient baseline characteristics

From: Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

Characteristics

Total number of patients

48

Median age (range)

62 (41–75) years

Gender

 

 Male

39 (81%)

 Female

9 (19%)

ECOG performance status

 

 0

23 (48%)

 1

24 (50%)

 2

1 (2%)

Disease status

 

 Newly diagnosed

37 (77%)

 Recurrent

11 (23%)

 Locally advanced

0 (0%)

 Metastatic

48 (100%)

Localisation of the primary tumour

 

 Stomach

23 (48%)

 Oesophagogastric junction

23 (48%)

 Gastric stump

2 (4%)

Sites of disease

 

 Liver

30 (63%)

 Lymph nodes

29 (60%)

 Peritoneum

16 (33%)

 Lung

13 (27%)

 Bone

5 (10%)

 Othersa

6 (12%)

  1. ECOG=Eastern Cooperative Oncology Group.
  2. aSkin (two patients), scrotum, adrenals, spleen and kidney.